1 |
2D solid-state hNH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
2 |
3D solid-state hCANH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
3 |
3D solid-state hCONH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
4 |
3D solid-state hCA(CO)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
5 |
3D solid-state hCO(CA)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
9 |
3D solid-state h(CA)CB(CACO)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
8 |
3D solid-state hN(CACO)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
7 |
3D solid-state H(NCACO)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
10 |
3D solid-state h(CA)CB(CA)NH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
6 |
2D hNH-resolved 1H-19F REDOR |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
11 |
2D FF Exchange |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |
12 |
2D water-edited solid-state hNH |
0.27 mg/uL [U-13C; U-15N; U-2H] Multidrug Resistance Protein E (EmrE), Complex with tetra(4-fluorophenyl)phosphonium, 9.5 ug/uL F4TPP, 0.44 mg/uL [U-99% 2H] d54-DMPC, bilayers |
0.07 |
bilayers |
8.0 |
1 |
285 |